Three UBC Medicine researchers are leading projects recently awarded funding through the Government of Canada’s New Frontiers in Research Fund (NFRF). Dr. Nadia Fairbairn, Dr. Joerg Gsponer and Dr. Calvin… Read More
VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (Cboe CA:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, announced that it has entered into agreements with Negev Capital Fund One,… Read More
VANCOUVER, BC – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, announced that… Read More
Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a potential increase of more than 12 million new annual… Read More
Research and development (R&D) play a crucial role in improving the health and well-being of patients all over the world. It leads to the development of new technologies and procedures… Read More
